Erica N Peters1, Robert P Schwartz2, Shuai Wang3, Kevin E O'Grady4, Carlos Blanco3. 1. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA; Yale University School of Medicine, SATU, One Long Wharf Drive, Box 18, New Haven, CT 06511, USA. Electronic address: epeters@friendsresearch.org. 2. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA. 3. Department of Psychiatry, New York State Psychiatric Institute/Columbia University, 1051 Riverside Drive, Unit 69, New York, NY 10032, USA. 4. Department of Psychology, University of Maryland, 300 Campus Drive, College Park, MD 20742, USA.
Abstract
BACKGROUND: Several gaps in the literature on individuals with co-occurring cannabis and tobacco use exist, including the extent of psychiatric, psychosocial, and physical health problems. We examine these gaps in an epidemiological study, the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), of a large, nationally representative sample. METHODS: The sample was drawn from Wave 2 NESARC respondents (N=34,653). Adults with current cannabis use disorders and nicotine dependence (CUD+ND) (n=74), CUD only (n=100), and ND only (n=3424) were compared on psychiatric disorders, psychosocial correlates (e.g., binge drinking; partner violence), and physical health correlates (e.g., medical conditions). RESULTS: Relative to those with CUD only, respondents with CUD+ND were significantly more likely to meet criteria for bipolar disorder, Clusters A and B personality disorders, and narcissistic personality disorder, and reported engaging in a significantly higher number of antisocial behaviors. Relative to those with ND only, respondents with CUD+ND were significantly more likely to meet criteria for bipolar disorder, anxiety disorders, and paranoid, schizotypal, narcissistic, and borderline personality disorders; were significantly more likely to report driving under the influence of alcohol and being involved in partner violence; and reported engaging in a significantly higher number of antisocial behaviors. CUD+ND was not associated with physical health correlates. CONCLUSIONS: Poor treatment outcomes for adults with co-occurring cannabis use disorders and nicotine dependence may be explained in part by differences in psychiatric and psychosocial problems.
BACKGROUND: Several gaps in the literature on individuals with co-occurring cannabis and tobacco use exist, including the extent of psychiatric, psychosocial, and physical health problems. We examine these gaps in an epidemiological study, the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), of a large, nationally representative sample. METHODS: The sample was drawn from Wave 2 NESARC respondents (N=34,653). Adults with current cannabis use disorders and nicotine dependence (CUD+ND) (n=74), CUD only (n=100), and ND only (n=3424) were compared on psychiatric disorders, psychosocial correlates (e.g., binge drinking; partner violence), and physical health correlates (e.g., medical conditions). RESULTS: Relative to those with CUD only, respondents with CUD+ND were significantly more likely to meet criteria for bipolar disorder, Clusters A and B personality disorders, and narcissistic personality disorder, and reported engaging in a significantly higher number of antisocial behaviors. Relative to those with ND only, respondents with CUD+ND were significantly more likely to meet criteria for bipolar disorder, anxiety disorders, and paranoid, schizotypal, narcissistic, and borderline personality disorders; were significantly more likely to report driving under the influence of alcohol and being involved in partner violence; and reported engaging in a significantly higher number of antisocial behaviors. CUD+ND was not associated with physical health correlates. CONCLUSIONS: Poor treatment outcomes for adults with co-occurring cannabis use disorders and nicotine dependence may be explained in part by differences in psychiatric and psychosocial problems.
Authors: D Robin Taylor; David M Fergusson; Barry J Milne; L John Horwood; Terrie E Moffitt; Malcolm R Sears; Richie Poulton Journal: Addiction Date: 2002-08 Impact factor: 6.526
Authors: Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini; Pere N Roset; Sandra Poudevida; Magi Farré; Jordi Segura; Rafael De la Torre Journal: JAMA Date: 2003-04-16 Impact factor: 56.272
Authors: Erin A McClure; Nathaniel L Baker; Susan C Sonne; Udi E Ghitza; Rachel L Tomko; LaTrice Montgomery; Shanna Babalonis; Garth E Terry; Kevin M Gray Journal: Drug Alcohol Depend Date: 2018-08-25 Impact factor: 4.492
Authors: Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis Journal: Neurotoxicol Teratol Date: 2018-09-26 Impact factor: 3.763
Authors: Kevin M Gray; Susan C Sonne; Erin A McClure; Udi E Ghitza; Abigail G Matthews; Aimee L McRae-Clark; Kathleen M Carroll; Jennifer S Potter; Katharina Wiest; Larissa J Mooney; Albert Hasson; Sharon L Walsh; Michelle R Lofwall; Shanna Babalonis; Robert W Lindblad; Steven Sparenborg; Aimee Wahle; Jacqueline S King; Nathaniel L Baker; Rachel L Tomko; Louise F Haynes; Ryan G Vandrey; Frances R Levin Journal: Drug Alcohol Depend Date: 2017-06-10 Impact factor: 4.492
Authors: Nathan A Gillespie; Steven H Aggen; Amanda E Gentry; Michael C Neale; Gun P Knudsen; Robert F Krueger; Susan C South; Nikolai Czajkowski; Ragnar Nesvåg; Eivind Ystrom; Tom H Rosenström; Fartein A Torvik; Ted Reichborn-Kjennerud; Kenneth S Kendler Journal: Twin Res Hum Genet Date: 2018-02 Impact factor: 1.587
Authors: Joan S Tucker; Anthony Rodriguez; Michael S Dunbar; Eric R Pedersen; Jordan P Davis; Regina A Shih; Elizabeth J D'Amico Journal: Drug Alcohol Depend Date: 2019-08-24 Impact factor: 4.492
Authors: Laura R Stroud; George D Papandonatos; Nancy C Jao; Chrystal Vergara-Lopez; Marilyn A Huestis; Amy L Salisbury Journal: Neurotoxicol Teratol Date: 2020-04-11 Impact factor: 3.763